Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report.

Masuccio, Fabio Giuseppe; Comi, Cristoforo; Solaro, Claudio

Masuccio, Fabio Giuseppe; Comi, Cristoforo; Solaro, Claudio.

Masuccio FG; Department of Rehabilitation, C.R.R.F. "Mons. L. Novarese", Loc. Trompone SNC, 13040, Moncrivello, Italy. fgmasuccio@gmail.com.
Comi C; Presidio Ospedaliero Sant'Andrea di Vercelli, Corso Abbiate 21, Vercelli, Italy.
Solaro C; Department of Translational Medicine, University of Eastern Piedmont Amedeo Avogadro School of Medicine, Via Solaroli 17, Novara, Italy.

Acta Neurol Belg ; 122(5): 1369-1371, 2022 10.

Article in English | MEDLINE | ID: covidwho-2048620

Subject(s)

2019-nCoV Vaccine mRNA-1273; COVID-19; Guillain-Barre Syndrome; 2019-nCoV Vaccine mRNA-1273/adverse effects; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Guillain-Barre Syndrome/etiology; Humans; SARS-CoV-2

Keywords

COVID-19 vaccine; GuillainBarrè syndrome; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 / 2019-nCoV Vaccine mRNA-1273 Type of study: Case report / Observational study Topics: Vaccines Limits: Humans Language: English Journal: Acta Neurol Belg Year: 2022 Document Type: Article Affiliation country: S13760-021-01838-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google